Cargando…
Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met
Aberrant activation of c-Met signalling plays a prominent role in cancer development and progression. A series of 12 imidazo [1,2-α] pyridine derivatives bearing 1,2,3-triazole moiety were designed, synthesized and evaluated for c-Met inhibitory potential and anticancer effect. The inhibitory activi...
Autores principales: | Damghani, Tahereh, Moosavi, Fatemeh, Khoshneviszadeh, Mehdi, Mortazavi, Motahareh, Pirhadi, Somayeh, Kayani, Zahra, Saso, Luciano, Edraki, Najmeh, Firuzi, Omidreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878917/ https://www.ncbi.nlm.nih.gov/pubmed/33574356 http://dx.doi.org/10.1038/s41598-021-83069-4 |
Ejemplares similares
-
Novel quinazoline-1,2,3-triazole hybrids with anticancer and MET kinase targeting properties
por: Mortazavi, Motahareh, et al.
Publicado: (2023) -
Study of the anticancer effect of new quinazolinone hydrazine derivatives as receptor tyrosine kinase inhibitors
por: Mortazavi, Motahareh, et al.
Publicado: (2022) -
Phenanthrotriazine Derivatives Containing Arylidine Hydrazone Moieties as Novel Potential c-Met Inhibitors with Anticancer Effect
por: Edraki, Najmeh, et al.
Publicado: (2021) -
Novel 5-oxo-hexahydroquinoline derivatives: design, synthesis, in vitro P-glycoprotein-mediated multidrug resistance reversal profile and molecular dynamics simulation study
por: Shahraki, Omolbanin, et al.
Publicado: (2017) -
5-Oxo-hexahydroquinoline Derivatives and Their Tetrahydroquinoline Counterparts as Multidrug Resistance Reversal Agents
por: Shahraki, Omolbanin, et al.
Publicado: (2020)